Experience from Martin Luther University - Halle, Germany, where the law of the land allows the employer to fire the employee without giving any reason immediately. Several researchers have had this trouble, and have been fired when their ideas were taken away from them in mere 3-4 months. So, please have a backup plan prepared if such a thing happens, as the European Commission or the local court or employee union will not be of any help and you would have no other choice than to go back home. Many previous researchers try approaching them but were unsuccessful and some had to pay penalty as well for trying to take action against the University, and the amount equaled the yearly salary of the fellow.
Unconfigured Ad
Collapse
This topic is closed.
X
X
-
-
Not in the first 6 month; that the usual probation period. In this period you can be fired without reasons, but you can also just leave.Originally posted by dpryan View PostUmm, it's incredibly difficult to just fire someone in Germany.
After this period it is clearly more difficult to fire someone; especially with a fix-term contract.
Comment
-
-
If they were fired during the Probezeit then sure, but I'm not sure who is coming up with ideas worth stealing as a student or even post-doc within that time.Originally posted by Michael.Ante View PostNot in the first 6 month; that the usual probation period. In this period you can be fired without reasons, but you can also just leave.
After this period it is clearly more difficult to fire someone; especially with a fix-term contract.
Comment
-
-
Citation: Case of Martin Luther University Dr Rujescu as employer at Halle(Saale).
Its more common in research because research jobs are all about ideas. Once the idea is generated, you would be disowned and fired, as they would not need you anymore , and others in the team will implement and publish your ideas on their name. 6 Month Probziet does goes to a severe strategic disadvantage to a foreign national, as even though they pay taxes and social contribution from their salary, unlike Germans, they are not entitled to any benefits once they are jobless as it requires minimum 1 year of job to get the benefits. The laws are carefully crafted to allow employers to cheat and misuse foreign employees in Germany.
BTW, my new book on bioinformatics based 'Genetic Engineering Strategies' just got published for which I am attaching part of its cover page for advertisement.Attached FilesLast edited by narain; 09-22-2016, 12:47 AM.
Comment
-
-
You missed out the point @ecSeq. I never said that GERMANS don't pay taxes and social contribution. Just that these money they pay they can get back if they get fired. This is not the case for foreign nationals. They have to pay the taxes and social contribution, and despite that you don't get any employment protection or social benefits it you get fired in first 6 months. The employer knows this and so uses this financial benefit information to their advantage to bring foreign scientists to Germany, take their ideas , and fire them without any reason in the first 6 months, publish the ideas on their own name.
Comment
-
-
@HESmith
A scientist/researcher work not just for money but also for reputation that gets generated via his idea and work. If someone steals your ideas that you worked and built upon, modifies it little bit here and there, and does not put you as co-author or even in acknowledgement , that is something ethically questionable for sure.
I do use this forum for technical questions as well, if you look at my previous messages. However, I don't think that this forum is limited only till technical questions, as I have seen people advertising new bioinformatics product, jobs, openings, papers, etc. Likewise, its absolutely useful to many (particularly the ones in the beginning of career), to know the practice in the trade. Such discussions of awareness in bioinformatics/research industry might not be useful for well established senior members like you, but I am sure a lot of the community do get benefitted by such discussions.
N
Comment
-
-
From the SEQanswers FAQs:
"While the site is intended to be oriented toward life sciences and next generation sequencing, any scientific topic related to genomics is open for discussion."
This lawsuit post has nothing to do with genomics. There are a few bad actors in every profession - research is no different. As you so eloquently state, reputations are important in our discipline. You impugn those reputations by claiming that idea theft is "the trade in the field."
Comment
-
-
@GenoMax - Point taken
@HESmith - I would say that the percentage is higher in this domain of ethically wrong people than in other domain in specific parts of the world, such as in Germany, and especially since the law itself is framed such that the employer can and should take maximum benefit from it.
Comment
-
-
@HESmith
I do have complete intentions to discuss technical issues of Genomics as well over here, as I have had in past. Its sad to learn that senior members like you do not want to talk about matters that matter as equally important for being a successful bioinformatician.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
23 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
215 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
79 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment